CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States

Abstract

Cytotoxic lymphocyte antigen-4 (CTLA-4) plays an important role in regulating T cell activation, and may help to limit T cell response under conditions of inflammation. Genetic variability in CTLA-4 has been implicated in the development of several autoimmune diseases. Some studies have described associations between CTLA-4 polymorphisms and systemic lupus erythematosus (SLE), but findings have been inconsistent. We examined polymorphisms in the CTLA-4 gene promoter region (21722T/C, 21661A/G, 2318C/T) and exon 1 (+49G/A) with respect to SLE in a population-based case-control study in the southeastern US. Genotypes from 230 recently diagnosed cases and 276 controls were examined separately for African-Americans and whites. We observed no overall associations between SLE and the four CTLA-4 polymorphisms examined. Subgroup analyses revealed effect modification by age for the presence of the 21661G allele, yielding a significant positive association with SLE in younger (≤35 years) African-Americans (OR = 3.3). CTLA-4 genotypes also interacted with HLA-DR2 and GM allotype to contribute to risk of SLE. These findings suggest allelic variation in this region of CTLA-4 is not a major independent risk factor for SLE, but may contribute to risk of disease in younger African-Americans or in the presence of certain immunogenetic markers.

Keywords

CTLA-4 effect modification genetics polymorphism population-based systemic lupus erythematosus

References

Salomon B , Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation . Annu Rev Immunol 2001; 19: 225-252 .

Chu EB , Hobbs MV , Wilson CB , Romball CG , Linsley PS , Weigle WO. Intervention of CD4+ cell subset shifts and autoimmunity in the BXSB mouse by murine CTLA4Ig . J Immunol 1996; 156: 1262-1268 .

Daikh DI , Finck BK , Linsley PS , Hollenbaugh D , Wofsy D. Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways . J Immunol 1997; 159: 3104-3108 .

Takiguchi M , Murakami M , Nakagawa I , Saito I , Hashimoto A , Uede T. CTLA4IgG gene delivery prevents autoantibody production and lupus nephritis in MRL/lpr mice . Life Sci 2000; 66: 991-1001 .

Schiffer L , Sinha J , Wang X et al. Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition . J Immunol 2003; 171: 489-497 .

Liu MF , Liu HS , Wang CR , Lei HY. Expression of CTLA-4 molecule in peripheral blood T lymphocytes from patients with systemic lupus erythematosus . J Clin Immunol 1998; 18: 392-398 .

Liu MF , Wang CR , Chen PC , Fung LL. Increased expression of soluble cytotoxic T-lymphocyte-associated antigen-4 molecule in patients with systemic lupus erythematosus . Scand J Immunol 2003; 57: 568-572 .

Kristiansen OP , Larsen ZM , Pociot F. CTLA-4 in autoimmune diseases—a general susceptibility gene to autoimmunity ? Genes Immun 2000; 1: 170-184 .

Moser KL , Neas BR , Salmon JE et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees . Proc Natl Acad Sci USA 1998; 95: 14869-14874 .

10.

Gaffney PM , Ortmann WA , Selby SA et al. Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analyses of 187 sib-pair families . Am J Hum Genet 2000; 66: 547-556 .

11.

Wang XB , Zhao X , Giscombe R , Lefvert AK. A CTLA-4 gene polymorphism at position 2318 in the promoter region affects the expression of protein . Genes Immun 2002; 3: 233-234 .

12.

Maurer M , Loserth S , Kolb-Maurer A et al. A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation . Immunogenetics 2002; 54: 1-8 .

13.

Ligers A , Teleshova N , Masterman T , Huang WX , Hillert J. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms . Genes Immun 2001; 2: 145-152 .

14.

Johnson GC , Esposito L , Barratt BJ et al. Haplotype tagging for the identification of common disease genes . Nat Genet 2001; 29: 233-237 .

15.

Hudson LL , Rocca K , Song YW , Pandey JP. CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region . Hum Genet 2002; 111: 452-455 .

16.

Blanco LF , Pampin EP , Gomez-Reino JJ , Gonzalez A. A 21722 CTLA- 4 polymorhpism associated with susceptiblity to systemic lupus erythematosus . Arthritis Rheum 2004; 50: 328-329 .

17.

Aguilar F , Torres B , Sanchez-Roman J , Nunez-Roldan A , Gonzalez-Escribano MF. CTLA4 polymorphism in Spanish patients with systemic lupus erythematosus . Hum Immunol 2003; 64: 936-940 .

18.

Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1997; 40: 1725-1725 .

19.

Cooper GS , Parks CG , Treadwell EL et al. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States . Lupus 2002; 11: 161-167 .

20.

Rothman KJ , Greenland S. Modern epidemiology. Philadelphia, PA: Lippincott-Raven , 1998.

21.

Heward J , Gordon C , Allahabadia A , Barnett AH , Franklyn JA , Gough SC. The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus . Ann Rheum Dis 1999; 58: 193-195 .

22.

Deichmann K , Heinzmann A , Bruggenolte E , Forster J , Kuehr J. An Mse I RFLP in the human CTLA4 promotor . Biochem Biophys Res Commun 1996; 225: 817-818 .

23.

Pandey JP , Cooper GS , Treadwell EL , Gilkeson GS , St Clair EW , Dooley MA. Immunoglobulin GM and KM allotypes in systemic lupus erythematosus . Exp Clin Immunogenet 2001; 18: 117-122 .

24.

Ota M , Seki T , Fukushima H , Tsuji K , Inoko H. HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers . Tissue Antigens 1992; 39: 187-202 .

25.

Alegre ML , Frauwirth KA , Thompson CB. T-cell regulation by CD28 and CTLA-4 . Nat Rev Immunol 2001; 1: 220-228 .

26.

Chang TT , Kuchroo VK , Sharpe AH. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease . Curr Dir Autoimmun 2002; 5: 113-130 .

27.

Bouqbis L , Izaabel H , Akhayat O et al. Association of the CTLA4 promoter region (21661G allele) with type 1 diabetes in the South Moroccan population . Genes Immun 2003; 4: 132-137 .

28.

Einarsdottir E , Soderstrom I , Lofgren-Burstrom A et al. The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto’s thyroiditis and Graves’ disease . Eur J Hum Genet 2003; 11: 81-84 .

29.

Matsushita M , Tsuchiya N , Shiota M et al. Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method . Tissue Antigens 1999; 54: 578-584 .

30.

Alizadeh M , Babron MC , Birebent B et al. Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients . Ann Neurol 2003; 54: 119-122 .

31.

Ahmed S , Ihara K , Kanemitsu S et al. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population . Rheumatology (Oxford) 2001; 40: 662-667 .

32.

Pullmann R Jr , Lukac J , Skerenova M et al. Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus . Clin Exp Rheumatol 1999; 17: 725-729 .

33.

Wang XB , Kakoulidou M , Giscombe R et al. Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence . J Neuroimmunol 2002; 130: 224-232 .

34.

Holopainen PM , Partanen JA. Technical note: linkage disequilibrium and disease-associated CTLA4 gene polymorphisms . J Immunol 2001; 167: 2457-2458 .

35.

Ueda H , Howson JM , Esposito L et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease . Nature 2003; 423: 506-511 .

36.

Oaks MK , Hallett KM , Penwell RT , Stauber EC , Warren SJ , Tector AJ. A native soluble form of CTLA-4 . Cell Immunol 2000; 201: 144-153 .

37.

Magistrelli G , Jeannin P , Herbault N et al. A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells . Eur J Immunol 1999; 29: 3596-3602 .

38.

Little J , Bradley L , Bray MS et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations . Am J Epidemiol 2002; 156: 300-310 .

39.

Wacholder S , Rothman N , Caporaso N. Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer . Cancer Epidemiol Biomarkers Prev 2002; 11: 513-520 .

40.

Liu MF , Wang CR , Lin LC , Wu CR. CTLA-4 gene polymorphism in promoter and exon-1 regions in Chinese patients with systemic lupus erythematosus . Lupus 2001; 10: 647-649 .

41.

Lee YH , Kim YR , Ji JD , Sohn J , Song GG. Polymorphisms of the CTLA-4 exon 1 and promoter gene in systemic lupus erythematosus . Lupus 2001; 10: 601-605 .

42.

D’ Alfonso S , Rampi M , Bocchio D , Colombo G , Scorza-Smeraldi R , Momigliano-Richardi P. Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10 . Arthritis Rheum 2000; 43: 120-128 .